# Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Canonical URL: https://biopharmsignal.com/news/LUNG/pulmonx-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-4-2026
Ticker: LUNG
Company: Pulmonx
Source: Pulmonx
Published: 2026-02-20 13:00 EST
Original Source URL: https://investors.pulmonx.com
## Summary

REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2025 after the close of trading

## Article Body
REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2025 after the close of trading
## Recent Company News
- 2026-07-15 20:05 EST — [Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026](https://biopharmsignal.com/news/LUNG/pulmonx-to-report-second-quarter-2026-financial-results-on-july-29-2026-aba8edf7) — Source: Pulmonx
- 2026-06-01 20:05 EST — [Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/LUNG/pulmonx-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Pulmonx
- 2026-04-29 20:05 EST — [Pulmonx Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LUNG/pulmonx-reports-first-quarter-2026-financial-results) — Source: Pulmonx
- 2026-04-28 20:05 EST — [Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference](https://biopharmsignal.com/news/LUNG/pulmonx-to-present-at-the-bank-of-america-securities-2026-health-care-conference) — Source: Pulmonx
- 2026-04-15 20:05 EST — [Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026](https://biopharmsignal.com/news/LUNG/pulmonx-to-report-first-quarter-2026-financial-results-on-april-29-2026) — Source: Pulmonx
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)